11.BETA.,16.ALPHA.,17,21-TETRAHYDROXY-5.ALPHA.,9-(EPOXY-1-ETHANYL-1-YLIDENEAMINO)PREGNANE-3,20-DIONE-16,17-ACETONIDE-21-ACETATE
UNII 742I36B23K
Substance Identification & Data
This profile provides standardized clinical and technical data for 11.beta.,16.alpha.,17,21-tetrahydroxy-5.alpha.,9-(epoxy-1-ethanyl-1-ylideneamino)pregnane-3,20-dione-16,17-acetonide-21-acetate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 742I36B23K.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 52091-92-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C28H39NO8 MBHGSCXGUTURDA-QAIFSOJDSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 11.beta.,16.alpha.,17,21-tetrahydroxy-5.alpha.,9-(epoxy-1-ethanyl-1-ylideneamino)pregnane-3,20-dione-16,17-acetonide-21-acetate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.